Delivery Order SPE2DB24D2013-SPE2DB25FCJZY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,379.08 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL format) on August 5, 2025, with completion scheduled for August 6, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting military and federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin pens with a ceiling value of $1,089.70. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,355.21 for Lantus SoloStar 100 Unit/mL 3 mL insulin pens on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price, non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,534.20 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical procurement supporting military and federal...
- The Defense Logistics Agency awarded a $3,049.07 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation, with performance to be executed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $1,053.04 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin pens (3ML). The contract is classified as firm fixed price with an ultimate completion date of August 26, 2025, and was competitively awarded with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $1,921.82 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This is a firm fixed price, competitively awarded contract with a completion date of August 11, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $1,260.50 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3 mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,461.26 for Lantus SoloStar 100 Unit/ML insulin pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a small-value pharmaceutical procurement to support federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJZYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an award date of August 25, 2025 and ultimate completion date of August 26, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed pricing and represents a small-value pharmaceutical transaction within the agency's medical supply chain operations. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, generic and brand-name drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, positioning AmerisourceBergen as a critical vendor within the DLA's pharmaceutical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/25/25 |